Navigation Links
Lilly's John Lechleiter Becomes PhRMA Board Chairman; Robert J. Hugin, Ian Read Assume New Posts
Date:4/13/2012

BOSTON, April 13, 2012 /PRNewswire-USNewswire/ -- John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association's annual meeting. Also elected were Celgene Corporation President, CEO, and Chairman Robert J. Hugin as chairman-elect of the PhRMA Board of Directors, and Ian C. Read, president and CEO of Pfizer, Inc., as board treasurer. 

(Logo: http://photos.prnewswire.com/prnh/20091027/PHRMALOGO )
 
Dr. Lechleiter succeeds Christopher Viehbacher, CEO of Sanofi, as PhRMA's chairman. 
 
"Chris has been indispensable to PhRMA on many fronts, providing invaluable leadership as the industry navigates the evolving policy and regulatory landscapes essential to continued innovation while always putting patients first," said PhRMA President and CEO John J. Castellani. "As Dr. Lechleiter assumes the chairman role, we can all feel comfort knowing that the patient-centered approaches we utilize in all our advocacy efforts will continue to be central to our mission of advancing innovation in the U.S and worldwide.  It is an honor to work closely with these visionary, passionate leaders of our sector." 

Dr. Lechleiter has served as chairman, president, and CEO of Lilly since 2008. He became president and chief operating officer of Lilly in 2005, when he joined the company's board of directors. His career at Lilly began in 1979 as a senior organic chemist in process research and development -- a department he later led in 1982. He was named executive vice president for pharmaceutical products and corporate development in 2001. In 2004, he became Lilly's executive vice president for pharmaceutical operations.

"I'm honored to lead PhRMA during this very important time in the history of our
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
2. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
3. Lilly CEO Lechleiter Outlines Opportunities for Improved Health and Economic Growth in Asia-Pacific Region
4. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
5. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
6. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
7. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
8. Fora Care Group Becomes Pioneering Educational Member of the International Society of Vascular Health
9. US Oncology Foundation Becomes Life Beyond Cancer Foundation
10. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
11. Triage Wireless, Inc. Becomes Sotera Wireless, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... and SOUTH SAN FRANCISCO, Calif. ... Pulmonary Fibrosis Foundation (PFF) and Veracyte, ... the organizations are partnering on a U.S. patient ... with interstitial lung diseases (ILDs), including idiopathic pulmonary ... (INTENSITY) survey will assess the steps and time ...
(Date:8/27/2015)... 27, 2015  QB3@953—a San Francisco ... of California (UC) research institute and biotech accelerator— ... to identify and facilitate collaborations to translate early ... The agreement formalizes a relationship between ... team and creates a new channel for DPAc ...
(Date:8/27/2015)... , Spain and CAMBRIDGE, Mass. , Aug. 27, ... presenting at the Rodman & Renshaw 17th Annual Global Investment ... at the St. Regis Hotel, ORYZON will be represented by ... Dr. Buesa will present this ... at the Fontainebleau Room (2nd Floor).  The company is completing ...
Breaking Medicine Technology:Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 2Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 3Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 4QB3@953 Signs Collaboration Agreement with GSK to Identify Early-Stage Drug Discovery Opportunities 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4
... EAST SETAUKET, N.Y., Dec. 19, 2011  An article in the ... of the National Academy of Sciences USA , reported ... therapeutic potential in a laboratory model of Gaucher disease  ... and president of Lixte said, "This is a novel ...
... MISSISSAUGA, Ontario, Dec. 19, 2011  Valeant Pharmaceuticals International, ... VRX) announced that effective December 16, 2011, the ... a dermatology unit of Sanofi (EURONEXT: SAN and ... International, Inc. Valeant Pharmaceuticals International, ...
Cached Medicine Technology:Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease 2Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease 3
(Date:8/27/2015)... ... August 27, 2015 , ... According to an article published ... released new guidelines to educate doctors and patients on the best practices for type ... came in 2007, so the new version is taking into account nearly a decade ...
(Date:8/27/2015)... Riverside, CA (PRWEB) , ... August 27, 2015 ... ... its plans to enter the exploding legal marijuana industry with the launch of ... adult consumers of legal marijuana to order products from their smart phones and ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... The Naderi ... now be offering Kybella, a cutting-edge, noninvasive procedure to improve submental fat. The ... Kybella provides permanent results without surgery. Dr. Kulak is the only Board Certified ...
(Date:8/27/2015)... FL (PRWEB) , ... August 27, 2015 , ... ... announce its partnership with Julia Glushko, professional Tennis player for Israel in the ... uses Zensah® Compression for all her training and recovery. , With a focus ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... and leading biopharmaceutical contract development manufacturing company (CDMO), announced today that it has ... for $205.68M in cash. , The addition of Cytovance Biologics to ...
Breaking Medicine News(10 mins):Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4
... in Spanish . , Researchers of the ... University of Granada (Spain) have discovered that extra virgin ... a paper published in the last issue of the renowned ... the bioactivity of polyphenols (this is, natural antioxidants) present in ...
... Patient Care launches fourth-year program that focuses on ... Feb. 5 /PRNewswire/ -- The Partnership ... effort led by southeastern Pennsylvania hospitals and one ... Blue Cross, announces its new initiatives for 2009-2011 ...
... It,s In Our Hands - Has Been Designed ... and Caregivers to Healthcare Resources and Services in ... the initiation of its Community Health Partnership (CHP), ... Bronx area, seeking to link Hispanic residents with ...
... /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin Board: ... developer, manufacturer and distributor in the People,s ... controlled subsidiary Beijing,Liang Fang Pharmaceutical Co., Ltd. ... million) in December 2008 for land use ...
... MinuteClinic, the pioneer and largest provider of ... that it has become a participating provider in ... South Carolina.BlueCross, Preferred Blue and Medicare Advantage members ... centers located in the Columbia and Greenville markets. ...
... 5 Palomar Medical Technologies, Inc. (Nasdaq: ... systems for cosmetic treatments, today announced financial results for ... Revenues for the quarter ended December 31, 2008 ... revenues, $2.2 million were royalty revenues, $0.5 million were ...
Cached Medicine News:Health News:Spanish scientists confirm extra virgin olive oil helps to combat breast cancer 2Health News:Region's Hospitals Engage in New Patient-Safety Efforts to Further Reduce Infections, Errors, and Improve Quality of Care 2Health News:Region's Hospitals Engage in New Patient-Safety Efforts to Further Reduce Infections, Errors, and Improve Quality of Care 3Health News:Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care 2Health News:Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care 3Health News:Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs 2Health News:Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs 3Health News:Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs 4Health News:Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs 5Health News:MinuteClinic Becomes Participating Provider With Preferred Blue Network of BlueCross BlueShield of South Carolina 2Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 2Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 3Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 4Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 5Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 6Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 7Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 8Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 9Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 10
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: